Stannous chloride API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Stannous chloride is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Stannous chloride or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Stannous chloride API 7772-99-8?

Description:
Here you will find a list of producers, manufacturers and distributors of Stannous chloride. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Stannous chloride 
Synonyms:
Stannous chloride anhydrous , Stannous chloride,anhydrous , Tin dichloride  
Cas Number:
7772-99-8 
DrugBank number:
DB11056 
Unique Ingredient Identifier:
R30H55TN67

General Description:

Stannous chloride, identified by CAS number 7772-99-8, is a notable compound with significant therapeutic applications. Stannous chloride is used as a source of tin in radiopharmaceutical kits. Tin reduces technetium-99m, the active radiological agent, allowing it to form a complex with phosphate-containing moeities . These complexes localize primarily in bone (40-50%) and infracted myocardium (0.01-0.02%/g of tissue) allowing for imaging of areas of altered osteogenesis or necrotic heart tissue .

Indications:

This drug is primarily indicated for: Stannous chloride is a component of technetium-99m agents indicated for imaging of the skeleton for areas of altered osteogenesis or in the detection of infarcted heart tissue . Its use in specific medical scenarios underscores its importance in the therapeutic landscape.

Pharmacodynamics:

Stannous chloride exerts its therapeutic effects through: Stannous chloride itself is not known to produce a pharmacological effect at the dosages used clinically. The drug's ability to modulate various physiological processes underscores its efficacy in treating specific conditions.

Mechanism of Action:

Stannous chloride functions by: Stannous chloride acts as a reducing agent for technetium-99m allowing formation of a Tc99m-Sn-pyrophosphate complex in combination sodium pyrophosphate . See for information on the active agent. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.

Classification:

Stannous chloride belongs to the class of inorganic compounds known as post-transition metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is a post-transition metal, classified under the direct parent group Post-transition metal chlorides. This compound is a part of the Inorganic compounds, falling under the Mixed metal/non-metal compounds superclass, and categorized within the Post-transition metal salts class, specifically within the Post-transition metal chlorides subclass.

Experimental Properties:

Further physical and chemical characteristics of Stannous chloride include:

  • Water Solubility: Freely soluble
  • Melting Point: 38